The Senate Committee on the Judiciary, Subcommittee on Antitrust, Competition Policy, and Consumer Rights yesterday held a hearing on the competitive implications of vertical mergers in the health care sector. The discussion focused on mergers involving pharmacy benefit managers, insurers and pharmacies, but also covered hospital acquisitions of physician offices. Testifying at the hearing were Craig Garthwaite, a professor at Northwestern University’s Kellogg School of Management; Thomas Greaney, a professor at the University of California Hastings College of the Law; Cory Capps, a partner at Bates White Economic Consulting; and Fiona Scott Morton, an economics professor at the Yale School of Management.
 

Related News Articles

Headline
A report released Jan. 9 by Kaufman Hall highlights hospital and health system merger and acquisition activity from last year.  The report said that…
Headline
The U.S. Chamber of Commerce Jan. 13 filed a lawsuit against the Federal Trade Commission, saying changes made by the FTC to premerger notification rules under…
Headline
The Federal Trade Commission Oct. 10 finalized changes to the premerger notification rules, form and instructions under the Hart-Scott-Rodino Antitrust…
Headline
The top three large-group insurers control an average of 82.2% of the market share in each state, nearly twice the combined average market share of each state’…
Headline
The Justice Department and the Federal Trade Commission Dec. 18 jointly issued the 2023 merger guidelines describing how the agencies review mergers and…
Headline
The U.S. District Court of the Eastern District of Louisiana Sept. 27 ruled in favor of a LCMC Health and Tulane University partnership, concluding that the…